Mapping Dimensional Aspects of Biobehavioral Threat Reactivity in Young, Violence-Exposed Children: Linkages to Fear and Distress

Information

  • Research Project
  • 10248455
  • ApplicationId
    10248455
  • Core Project Number
    U01MH113390
  • Full Project Number
    5U01MH113390-04
  • Serial Number
    113390
  • FOA Number
    PA-16-160
  • Sub Project Id
  • Project Start Date
    9/1/2018 - 5 years ago
  • Project End Date
    6/30/2023 - a year ago
  • Program Officer Name
    BORJA, SUSAN
  • Budget Start Date
    8/13/2021 - 2 years ago
  • Budget End Date
    6/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    04
  • Suffix
  • Award Notice Date
    8/13/2021 - 2 years ago

Mapping Dimensional Aspects of Biobehavioral Threat Reactivity in Young, Violence-Exposed Children: Linkages to Fear and Distress

PROJECT SUMMARY: Interpersonal violence (IV) affects more than 1 in 5 young children in the United States annually. For young children, IV exposure most commonly occurs within the family context in the forms of partner violence and harsh/abusive parenting. Children exposed to IV represent a heterogeneous group. A portion of children develop psychological problems that cut across multiple diagnostic categories characterized by fear and distress symptoms. Existing models broadly implicate disruptions in biological stress systems in the etiology of violence-associated symptoms, but lack specificity for explaining heterogeneous symptom presentations in young children. Advancing this science requires novel laboratory and analytic methods for assessing and synthesizing threat reactivity across multiple biobehavioral levels. Inspired by the Research Domain Criteria (RDoC) initiative, we propose to achieve this by leveraging person-centered methods to identify unique profiles of threat reactivity across multiple levels of biobehavioral functioning never before studied together in young children: observed behavior, attention bias, autonomic reactivity, startle, event-related brain potentials. The fundamental scientific premise of the proposed work is that threat reactivity is a central intermediate phenotype linking early IV to this clinical vulnerability in young children. The proposed sample will include 360 children, ages 4 to 6 years, with (n = 240) and without (n = 120) IV exposure followed over 1 year. We advance three aims. Aim 1 is to map biobehavioral threat reactivity profiles to dimensional patterns of fear and distress in IV exposed and non-exposed young children. We hypothesize that we will identify hyper- and hypo-reactive profiles that link to greater symptoms relative to a non-extreme profile, and that hyper-reactivity will relate to fear, whereas hypo-reactivity will relate to distress at baseline and over 1 year. Aim 2 is to test whether threat reactivity profiles serve as intermediate phenotypes in explaining the link between violence exposure and symptoms over time. We hypothesize that children exposed to more severe IV will more likely be classified as hyper- or hypo-reactive and that profile type will mediate the link between IV and symptoms at baseline and 1 year later. Further, given high dependency of young children?s self-regulation on caregiving relationships and threats to regulatory capacity in violent environments, we hypothesize that mothers? ability to co-regulate their children?s negative affect will shape these risk pathways. Thus, Aim 3 is to test the hypothesis that maternal responsiveness to child negative affect will play a unique role in shaping threat reactivity pathways over time. We hypothesize that emotionally-responsive parenting (assessed with a multi-method protocol) will buffer the associations between IV and threat reactivity profiles and between exposure and symptom trajectories over 1 year. This study will provide critical insight into the etiology of violence-related psychopathology with key implications for developing novel approaches for identification, prevention, and intervention for these highly vulnerable young children.

IC Name
NATIONAL INSTITUTE OF MENTAL HEALTH
  • Activity
    U01
  • Administering IC
    MH
  • Application Type
    5
  • Direct Cost Amount
    551691
  • Indirect Cost Amount
    193572
  • Total Cost
    745263
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    242
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIMH:745263\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    CPDD
  • Study Section Name
    Child Psychopathology and Developmental Disabilities Study Section
  • Organization Name
    UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
  • Organization Department
    PSYCHIATRY
  • Organization DUNS
    022254226
  • Organization City
    FARMINGTON
  • Organization State
    CT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    060305335
  • Organization District
    UNITED STATES